Pulse Biosciences (NASDAQ:PLSE) Trading Down 2.9% – Here’s Why

Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 2.9% during mid-day trading on Friday . The stock traded as low as $16.68 and last traded at $16.50. 87,431 shares traded hands during trading, a decline of 42% from the average session volume of 150,826 shares. The stock had previously closed at $16.99.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Pulse Biosciences to a “sell” rating in a research report on Thursday, January 2nd.

Pulse Biosciences Trading Down 0.5 %

The firm’s 50-day moving average price is $19.22 and its two-hundred day moving average price is $18.29.

Hedge Funds Weigh In On Pulse Biosciences

A number of large investors have recently made changes to their positions in PLSE. Tower Research Capital LLC TRC raised its position in shares of Pulse Biosciences by 98.1% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,692 shares of the company’s stock worth $29,000 after purchasing an additional 838 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in Pulse Biosciences during the fourth quarter worth about $44,000. Caisse Des Depots ET Consignations acquired a new position in Pulse Biosciences during the fourth quarter valued at approximately $95,000. Farther Finance Advisors LLC raised its position in Pulse Biosciences by 44.4% in the fourth quarter. Farther Finance Advisors LLC now owns 7,220 shares of the company’s stock valued at $126,000 after purchasing an additional 2,220 shares during the period. Finally, SG Americas Securities LLC acquired a new position in Pulse Biosciences during the 4th quarter worth approximately $193,000. Hedge funds and other institutional investors own 76.95% of the company’s stock.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.